POP Biotechnologies Employee Directory
Biotechnology ResearchNew York, United States2-10 Employees
POP Biotechnologies is a small biotechnology company based in Buffalo, New York, focused on developing biomedical solutions through next-generation nanotechnologies. It aims to advance vaccines and therapeutics, including a SNAP protein vaccine platform that uses nanoliposome-based delivery to present antigens. The firm operates within the biotechnology research sector and pursues collaborations to move innovative vaccine concepts toward clinical evaluation. With a compact team, the company concentrates its efforts in the Buffalo area as part of the broader U.S. biotechnology ecosystem. An illustrative development occurred in 2024 when POP Biotechnologies began dosing a shingles vaccine candidate, EuHZV, in a Phase 1 study in Korea under a collaboration with EuBiologics. These activities reflect the company's focus on advancing next-generation vaccines through partnerships that broaden their development opportunities within the global biotech landscape.
1-888-653-2347 
support@leadiq.com 
